Müzeyyen Aslaner Ak

6PUBLICATIONS
118CO-AUTHORS
Te urupare me te whai wāhi Māori ki te mātauranga (Māori responsiveness and engaged education)Haematological tumoursRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 14, 2023
Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye

Atakan Tekinalp, Ayfer Gedük, Aydan Akdeniz

|Feb 17, 2023
Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data

Müzeyyen Aslaner Ak, Ayfer Gedük, İbrahim Halil Acar

|May 02, 2022
The Clinical Efficacy of Epoetin Alfa and Darbepoetin Alfa in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Retrospective Multi-center Real-Life Study.

Muzeyyen Aslaner Ak, Birsen Sahip, Ayfer Geduk

|Apr 25, 2022
Tyrosine kinase inhibitor nilotinib induced palmoplantar erythrodysesthesia: A rare case.

Muzeyyen Aslaner Ak, Pelin Ertop Doğan, Birsen Sahip

|Dec 14, 2020
Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey

Nur Soyer, Rıdvan Ali, Mehmet Turgut

|Jul 23, 2019
A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

Demet Çekdemir, Serkan Güvenç, Füsun Özdemirkıran

Pageof 1

Frequent Collaborators

3 joint publications

Şehmus Ertop

3 joint publications

Güray Saydam

2 joint publications

Volkan Karakuş

2 joint publications

Gülsüm Özet